Oxford researchers have been awarded funding to conduct a study comparing a new type of MRI (Magnetic resonance imaging) to standard of care ultrasound for liver cancer surveillance in people with cirrhosis. The University of Oxford’s DeLIVER team, which is investigating early detection methods ... READ MORE
News for Cancer
Study assesses long-term risk of invasive breast cancer after pre-invasive disease
A new study has provided evidence that women who have been diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening programme are around four times as likely to develop invasive breast cancer and to die from breast cancer than women in the general population. The study by ... READ MORE
Oxford BRC-funded paper named BMJ UK Research Paper of the Year
A study supported by the NIHR Oxford Biomedical Research Centre (BRC) has been named The BMJ UK Research Paper of the Year 2023. The study by researchers at Oxford Population Health into breast cancer mortality rates found that women diagnosed with early-stage breast cancer today are 66% ... READ MORE
Collaboration announced for develop use of AI to evaluate Barrett’s oesophagus
Technology to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus that was devised in a study supported by the NIHR Oxford Biomedical Research Centre (BRC) is to be developed as part of a new collaboration between the University of Oxford and Satisfai Health, a ... READ MORE
Tumour monocyte content can predict immunochemotherapy outcomes, study shows
A team of Oxford researchers has discovered a link between immune cells known as monocytes in tumours and overall survival in patients with oesophageal cancer. A study by Ludwig Cancer Research, supported by the NIHR Oxford Biomedical Research Centre (BRC) found that the presence of relatively ... READ MORE
Women diagnosed with early breast cancer less likely to die from disease than 20 years ago
A study conducted by researchers at Oxford Population Health has found that women who are diagnosed with early-stage breast cancer today are 66 percent less likely to die from the disease within five years of diagnosis than they were 20 years ago. The study, which was funded by Cancer Research ... READ MORE
Multi-cancer blood test shows real promise in NHS trial
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms. The test also correctly identified the original site of cancer in 85 percent of those cases. The ... READ MORE
Research profile: the importance of doing research alongside clinical work
Francesca Tabacchi, a specialist oncology dietitian at Oxford University Hospitals, is currently being funded by the NIHR Oxford Biomedical Research Centre to do a PhD on malnutrition and nutritional support in cancer patients undergoing chemotherapy. “I was very excited to start my research ... READ MORE
New tool uses health records to predict risk of developing lung cancer
Researchers from the Universities of Oxford and Nottingham have developed a new tool that can identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives. The researchers ... READ MORE
Prostate cancer AI diagnosis tool begins evaluation in Oxford
New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help ... READ MORE
Genetic ‘marker’ linked to side-effects from skin cancer treatment found
New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for one of the most common skin cancers. The study, which was supported by the NIHR Oxford Biomedical Research Centre ... READ MORE
Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination
A study has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly. The study, published in ... READ MORE
Cancer Research UK to invest £11 million into cancer science in Oxford
Cancer Research UK has invested £11 million in the University of Oxford and Oxford-based NHS to accelerate the translation of its world-leading cancer research for patient benefit. The highly competitive Cancer Research UK Centre awards recognise the UK’s most innovative, high-impact cancer ... READ MORE
New multi-cancer early detection blood test study opens
Volunteers in Oxfordshire are taking part in a new study that will trial a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear. The aim of the SYMPLIFY study, which is being led by the University of Oxford and is open at Oxford University Hospitals ... READ MORE
First person receives drug designed to re-sensitise patients to cancer treatment
The first patient has been dosed using a new drug aimed at improving treatment options for melanoma and non-small cell lung cancer (NSCLC) and re-sensitising patients with checkpoint therapy-resistant tumours The IMP-MEL clinical trial began in Oxford with its first patient being dosed with the ... READ MORE
Oxford Cancer launched at the University of Oxford
Oxford Cancer has been launched to represent and coordinate cancer research in Oxford. The pan-divisional initiative has been launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city. With more than 900 ... READ MORE
Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens
University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound. The Phase I PanDox study, which is supported by the ... READ MORE
Oxford wins government funding to evaluate prostate cancer detection system
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by the digital diagnostic company Paige, will be investigated in a multicentre clinical study led by the University of Oxford as part of a successful NHSX Artificial Intelligence ... READ MORE
AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer. In a research paper published in the journal ... READ MORE
Artificial intelligence tool for streamlining pathology workflow
A multidisciplinary team comprising University of Oxford academics and Oxford University Hospitals (OUH) pathologists has developed an algorithm that automates requests for additional investigation of diagnostically uncertain prostate biopsies. The team were supported by the NIHR Oxford BRC ... READ MORE
- 1
- 2
- 3
- 4
- Next Page »